Comparison of Off-Pump CABG and Multivessel MIDCAB: A Propensity Score-Matched Single-Center Analysis of Perioperative and Short-Term Outcomes
The Thoracic and Cardiovascular Surgeon · 01.01.2026 · 74 (S 01 S 01) · S1-S70
DOI: 10.1055/s-0046-1817259 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.01.2026. Verfasst von I. Krasivskyi und 8 weiteren Autor:innen.
Abstract (Originalsprache)
All articles of this category (opens in new window)
Background
The optimal revascularization strategy for multivessel coronary artery disease remains a central challenge in cardiac surgery. This study compares the perioperative and short-term clinical outcomes of Off-Pump Coronary Artery Bypass Grafting (OPCAB) with the minimally invasive multivessel Direct Coronary Artery Bypass (MV-MIDCAB) technique to clarify their respective advantages and limitations.
Methods
In a retrospective, single-center analysis, 620 consecutive patients (December 2021–February 2025) undergoing OPCAB ( n = 440) or MV-MIDCAB ( n = 180) were evaluated. Using propensity score matching (1:1), 118 patient pairs were formed to ensure comparable baseline characteristics. Primary endpoints included in-hospital mortality, stroke, and acute kidney injury (AKI). Secondary endpoints were completeness of revascularization, need for re-thoracotomy, and length of stay in the intensive care unit (ICU) and hospital.
Results
After propensity score matching, both groups showed comparable demographics and comorbidities (age: 66 ± 9 years; EuroScore II: 1.8 ± 1.2 vs. 1.7 ± 1.7). The MV-MIDCAB group exhibited a significantly lower rate of complete revascularization (55.1% vs. 85.5%, p < 0.001) and demonstrated a higher utilization of the aorta-no-touch technique (100% vs. 78.0%, p < 0.001). The use of two internal thoracic artery (ITA) grafts was less frequent in the MV-MIDCAB group (19.5% vs. 65.8%, p < 0.001). Postoperatively, the incidence of AKI was significantly higher in the MV-MIDCAB group (5.1% vs. 0%, p = 0.029). No significant differences were found for stroke (0.8% vs. 0%), delirium (11.0% vs. 5.1%, p = 0.150), re-thoracotomy, or length of stay (ICU: 1.6 vs. 1.7 days, p = 0.498). In-hospital mortality was 0% in both groups.
Conclusion
While MV-MIDCAB allows for complete aorta-no-touch revascularization, it is associated with reduced completeness of revascularization and an increased risk of acute kidney injury. OPCAB, conversely, offers a superior revascularization rate without a significant increase in morbidity or mortality. These findings underscore the necessity for careful patient selection and further prospective studies to evaluate the long-term outcomes of both procedures. Publication History Article published online: 17 February 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Krasivskyi, I., Romero, C. O., Alirezaei, H., Alaj, E., Ciobanu, V., Hamiko, M., Monsefi, N., Bakhtiary, F., & Eghbalzadeh, K. (2026). Comparison of Off-Pump CABG and Multivessel MIDCAB: A Propensity Score-Matched Single-Center Analysis of Perioperative and Short-Term Outcomes. The Thoracic and Cardiovascular Surgeon, 74(S 01 S 01), S1-S70. https://doi.org/10.1055/s-0046-1817259
Vancouver
Krasivskyi I, Romero CO, Alirezaei H, Alaj E, Ciobanu V, Hamiko M, et al. Comparison of Off-Pump CABG and Multivessel MIDCAB: A Propensity Score-Matched Single-Center Analysis of Perioperative and Short-Term Outcomes. The Thoracic and Cardiovascular Surgeon. 2026;74(S 01 S 01):S1-S70. doi:10.1055/s-0046-1817259
BibTeX
@article{Krasivskyi2026,
author = {Krasivskyi, I. and Romero, CA. Origel and Alirezaei, H. and Alaj, E. and Ciobanu, V. and Hamiko, M. and Monsefi, N. and Bakhtiary, F. and Eghbalzadeh, K.},
title = {Comparison of Off-Pump CABG and Multivessel MIDCAB: A Propensity Score-Matched Single-Center Analysis of Perioperative and Short-Term Outcomes},
journal = {The Thoracic and Cardiovascular Surgeon},
year = {2026},
volume = {74},
number = {S 01 S 01},
pages = {S1--S70},
doi = {10.1055/s-0046-1817259}
}
EUVIMED